Specify the comparator and the evidence plan before committing to enhanced-absorption language.
The source context
FTC guidance calls for scientific support that fits the product and the claim being made. An attractive delivery-system description does not, by itself, substantiate a health or performance claim. Source ↗
PCG perspective · The following is our proposed development framework, not a finding of the cited source.
Define what is being compared
An absorption proposition needs a clear comparator. Ask whether the comparison is to a specific conventional formulation, a different dose, or another delivery format. Record the ingredient form, serving, and conditions of use. Without that clarity, development teams can discuss improved performance while referring to different questions, and marketing teams can inherit a conclusion broader than the work supports.
Keep mechanism and outcome separate
A plausible formulation mechanism can justify further investigation. It does not automatically establish the size, consistency, or practical importance of an effect in people. Treat mechanistic reasoning, laboratory characterization, and human evidence as different inputs. This distinction helps the team choose the next experiment and avoids turning a supplier presentation into a finished-product promise.
Create the research brief before the headline
Describe the question, comparator, population, measurements, and decision the study will inform. Ask a qualified research partner what design is appropriate and which limitations would remain even after a positive result. Budget for interpretation as well as execution. A study has more commercial value when the team understands what it can responsibly say afterward.
Track formulation changes
A change to the ingredient source, processing, serving, or delivery system may affect the relevance of prior evidence. Maintain version control between the tested product and the commercial specification. Before reusing an existing claim, review whether the evidence still matches. That discipline is especially important when cost, scale, or supply constraints lead to substitutions during commercialization.
Source & scope
FTC Health Products Compliance Guidance ↗US guidance; checked September 21, 2026. Sources checked September 21, 2026. Product-specific scientific and regulatory conclusions require appropriate specialist review.
How we prepare and update insightsRelated PCG service
Novel delivery systems & bioavailability development ↗Turn the question into a development brief.
Explore formulation, sourcing, research, or portfolio decisions with Product Concept Group.
Discuss this opportunity ↗